Australia’s Personal Importation Scheme allows some therapeutic goods to be brought in for an individual or their immediate family, subject to conditions. It is not a general permission to order any medicine sold overseas. The packaging, prescription evidence, quantity and ingredients all matter.
The Therapeutic Goods Administration updated its public conditions on 8 September 2026. A useful first distinction is how the goods enter the country: a parcel sent by an overseas supplier and medicine carried by a traveller fall under different pathways.
What changed about packaging
The TGA’s announcement explains the purpose of the change: authorities need to identify what is being imported. Unidentified, mislabelled and counterfeit products create different problems from a clearly identified medicine accompanied by the required documentation.
The announcement highlights original packaging, dispensing labels and product information where possible. It also describes clarifications about goods covered by the scheme, immediate-family relationships and evidence for travellers carrying prescription medicines.
A useful way to read that explanation is to separate three kinds of information. Packaging identifies the product. A prescription or other written authority establishes the relevant prescribing information. Import conditions determine whether that product and quantity can use the pathway. One document does not automatically perform all three jobs.
The conditions for a shipment
The current Personal Importation Scheme guidance describes goods typically sent by mail or courier. They must be for personal or specified immediate-family use, without onward sale or supply. Prescription-only medicines require a valid Australian prescription or written authority held at the time of importation.
The normal limit is a three-month supply per import and no more than a fifteen-month supply within twelve months. Products need original packaging or packaging allowing accurate identification. The scheme excludes vaping products, controlled substances and goods prohibited under customs or quarantine rules.
The TGA says electronic prescriptions cannot currently be accepted as the required written authority for this process because of missing details and verification limitations. Obtaining a prescription after a shipment has been held does not retrospectively satisfy the requirement to hold it at importation.
These conditions describe the scheme; they do not establish that a particular order meets them. The ingredient, product classification and quantity need to be considered together. An overseas seller’s willingness to ship is not an assessment by Australian authorities.
Carrying medicine on a trip is a separate question
The traveller-exemption guidance covers certain medicines and devices carried for the traveller or an immediate family member travelling with them. It describes original packaging, prescription or doctor-letter evidence for prescription medicines, and a usual three-month limit.
It also prohibits onward sale or supply and explains that particular products can have additional rules. The guidance directs travellers to the Australian Border Force and Office of Drug Control for controlled-medicine requirements.
That is why a visitor should not simply copy the mail-order scheme’s Australian-prescription rule onto every accompanied-baggage situation. Conversely, an exemption for carrying a medicine does not automatically authorise a later parcel containing it. A longer stay can involve more than one process, each with its own evidence requirements.
Permission to import is different from product evaluation
The personal-import scheme can cover goods not entered in the Australian Register of Therapeutic Goods. Meeting an import pathway’s conditions is therefore different from the TGA having evaluated that product for its safety, quality and effectiveness.
This distinction also applies to authenticity. A prescription does not establish that an overseas supplier has provided a genuine product, and original-looking packaging does not by itself establish what a parcel contains.
For readers organising an import, the useful sequence is to identify the correct pathway, read its current requirements and check the product-specific restrictions. The TGA’s linked guidance is the maintained source for those conditions; a retailer’s checkout, a travel anecdote or another country’s rules cannot settle an Australian border decision.